BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirche TO, Knoop C, Hebestreit H, Shimmin D, Solé A, Elborn JS, Ellemunter H, Aurora P, Hogardt M, Wagner TO; ECORN-CF Study Group. Practical guidelines: lung transplantation in patients with cystic fibrosis. Pulm Med 2014;2014:621342. [PMID: 24800072 DOI: 10.1155/2014/621342] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Borchi B, Barao Ocampo M, Cimino G, Pizzamiglio G, Bresci S, Braggion C; Italian Cystic Fibrosis Lung Transplantation Group. Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation: a survey of Italian CF centers. Ital J Pediatr 2018;44:72. [PMID: 29954414 DOI: 10.1186/s13052-018-0512-y] [Reference Citation Analysis]
2 Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519-2531. [PMID: 27140670 DOI: 10.1016/s0140-6736(16)00576-6] [Cited by in Crossref: 740] [Cited by in F6Publishing: 364] [Article Influence: 123.3] [Reference Citation Analysis]
3 Marczin N, de Waal EEC, Hopkins PMA, Mulligan MS, Simon A, Shaw AD, Van Raemdonck D, Neyrinck A, Gries CJ, Algotsson L, Szegedi L, von Dossow V; Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members):., Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members):., Independent Reviewers:. International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. J Heart Lung Transplant 2021;40:1327-48. [PMID: 34732281 DOI: 10.1016/j.healun.2021.07.012] [Reference Citation Analysis]
4 Solé A, Pérez I, Vázquez I, Pastor A, Escrivá J, Sales G, Hervás D, Glanville AR, Quittner AL. Patient-reported symptoms and functioning as indicators of mortality in advanced cystic fibrosis: A new tool for referral and selection for lung transplantation. The Journal of Heart and Lung Transplantation 2016;35:789-94. [DOI: 10.1016/j.healun.2016.01.1233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
5 Lynch JP 3rd, Sayah DM, Belperio JA, Weigt SS. Lung transplantation for cystic fibrosis: results, indications, complications, and controversies. Semin Respir Crit Care Med 2015;36:299-320. [PMID: 25826595 DOI: 10.1055/s-0035-1547347] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
6 de Kretser DM, Bensley JG, Phillips DJ, Levvey BJ, Snell GI, Lin E, Hedger MP, O'Hehir RE. Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation. PLoS One 2016;11:e0140948. [PMID: 26820896 DOI: 10.1371/journal.pone.0140948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Krivchenia K, Tumin D, Tobias JD, Hayes D. Increased Mortality in Adult Cystic Fibrosis Patients with Medicaid Insurance Awaiting Lung Transplantation. Lung 2016;194:799-806. [DOI: 10.1007/s00408-016-9927-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Ju L, Suberbielle C, Li X, Mooney N, Charron D. HLA and lung transplantation. Front Med 2019;13:298-313. [DOI: 10.1007/s11684-018-0636-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Giorgia G, Iacopo C, Elisa C, Morlacchi LC, Valeria R, Lorenzo R, Ilaria R, Mario N, Maura A, Francesco B, Cristina EV. Impact of bone-active drugs and underlying disease on bone health after lung transplantation: A longitudinal study. J Cyst Fibros 2021:S1569-1993(21)01327-8. [PMID: 34366281 DOI: 10.1016/j.jcf.2021.07.013] [Reference Citation Analysis]
10 Rath M, Najm J, Gilberg E, Felbor U. Mukoviszidose: Screening im Neugeborenenalter und mutationsspezifische Therapieansätze. Medizinische Genetik 2016;28:355-75. [DOI: 10.1007/s11825-016-0105-3] [Reference Citation Analysis]
11 Ziegler B, Perin C, Casarotto FC, Fagondes SC, Menna-Barreto SS, Dalcin PTR. Pulmonary hypertension as estimated by Doppler echocardiography in adolescent and adult patients with cystic fibrosis and their relationship with clinical, lung function and sleep findings. Clin Respir J 2018;12:754-61. [PMID: 27925430 DOI: 10.1111/crj.12590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Wietlisbach M, Benden C, Koutsokera A, Jahn K, Soccal PM, Radtke T. Perceptions towards physical activity in adult lung transplant recipients with cystic fibrosis. PLoS One 2020;15:e0229296. [PMID: 32084221 DOI: 10.1371/journal.pone.0229296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Schwarz C, Hartl D, Eickmeier O, Hector A, Benden C, Durieu I, Sole A, Gartner S, Milla CE, Barry PJ. Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis. Mycopathologia 2018;183:21-32. [DOI: 10.1007/s11046-017-0182-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
14 Kapnadak SG, Dimango E, Hadjiliadis D, Hempstead SE, Tallarico E, Pilewski JM, Faro A, Albright J, Benden C, Blair S, Dellon EP, Gochenour D, Michelson P, Moshiree B, Neuringer I, Riedy C, Schindler T, Singer LG, Young D, Vignola L, Zukosky J, Simon RH. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. Journal of Cystic Fibrosis 2020;19:344-54. [DOI: 10.1016/j.jcf.2020.02.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
15 Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A. Cystic fibrosis. Nat Rev Dis Primers 2015;1:15010. [PMID: 27189798 DOI: 10.1038/nrdp.2015.10] [Cited by in Crossref: 218] [Cited by in F6Publishing: 191] [Article Influence: 31.1] [Reference Citation Analysis]
16 Hollander-Kraaijeveld FM, van Lanen AS, de Roos NM, van de Graaf EA, Heijerman HGM. Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement. J Cyst Fibros 2020;19:975-80. [PMID: 32291160 DOI: 10.1016/j.jcf.2020.03.013] [Reference Citation Analysis]
17 Martin C, Reynaud-gaubert M, Hamidfar R, Durieu I, Murris-espin M, Danner-boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Lemonnier L, Burnet E, Paillasseur J, Da Silva J, Burgel P. Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis. Journal of Cystic Fibrosis 2022. [DOI: 10.1016/j.jcf.2022.01.012] [Reference Citation Analysis]
18 Chalasti M, Iordanou C, Kratiras Z, Stylianaki A, Trigka EA, Lakiotaki E, Makedou K, Iliadis S, Zografos KG, Dimitroulis D, Chrisofos M, Patsouris E, Zografos GC, Bouboulis GC, Papalois AE. Experimental isolation and preservation of solid organs before transplantation: effects of pretreatment using four different molecules. J Int Med Res 2020;48:300060520933452. [PMID: 32602766 DOI: 10.1177/0300060520933452] [Reference Citation Analysis]
19 Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D Jr. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med 2018;12:893-904. [PMID: 30198350 DOI: 10.1080/17476348.2018.1522254] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Prabhu M, Valchanov K. Pre-anaesthetic evaluation of the patient with end-stage lung disease. Best Pract Res Clin Anaesthesiol 2017;31:249-60. [PMID: 29110797 DOI: 10.1016/j.bpa.2017.05.002] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Hota P, Madan R. Cystic Fibrosis from Childhood to Adulthood. Radiologic Clinics of North America 2020;58:475-86. [DOI: 10.1016/j.rcl.2019.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Swisher AK, Hebestreit H, Mejia-downs A, Lowman JD, Gruber W, Nippins M, Alison J, Schneiderman J. Exercise and Habitual Physical Activity for People With Cystic Fibrosis: Expert Consensus, Evidence-Based Guide for Advising Patients. Cardiopulmonary Physical Therapy Journal 2015;26:85-98. [DOI: 10.1097/cpt.0000000000000016] [Cited by in Crossref: 19] [Article Influence: 2.7] [Reference Citation Analysis]
23 Burgel PR, Lemonnier L, Dehillotte C, Sykes J, Stanojevic S, Stephenson AL, Paillasseur JL. Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year death. Eur Respir J 2019;53:1801943. [PMID: 30578399 DOI: 10.1183/13993003.01943-2018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
24 Silva GF, J Simmonds N, Roth Dalcin PT. Clinical characteristics and outcomes in adult cystic fibrosis patients with severe lung disease in Porto Alegre, southern Brazil. BMC Pulm Med 2020;20:194. [PMID: 32677921 DOI: 10.1186/s12890-020-01223-6] [Reference Citation Analysis]
25 Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibros. 2014;13 Suppl 1:S23-S42. [PMID: 24856775 DOI: 10.1016/j.jcf.2014.03.010] [Cited by in Crossref: 300] [Cited by in F6Publishing: 228] [Article Influence: 42.9] [Reference Citation Analysis]
26 Hoechter DJ, von Dossow V. Lung transplantation: from the procedure to managing patients with lung transplantation. Current Opinion in Anaesthesiology 2016;29:8-13. [DOI: 10.1097/aco.0000000000000268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
27 Yang C, Xi Y, Chen WY, Sang L, Liu DD, Zhang R, Chen SB, Zhang J, Pan JY, Xv YH, Nong LB, Li YM, Liu XQ. Conversion ratio of tacrolimus switching from intravenous infusion to oral administration after lung transplantation. J Thorac Dis 2020;12:4292-8. [PMID: 32944341 DOI: 10.21037/jtd-20-1191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Cairoli E, Eller-Vainicher C, Morlacchi LC, Tarsia P, Rossetti V, Pappalettera M, Arosio M, Chiodini I, Blasi F. Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure. Osteoporos Int 2019;30:1255-63. [PMID: 30798331 DOI: 10.1007/s00198-019-04893-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Nkam L, Lambert J, Latouche A, Bellis G, Burgel PR, Hocine MN. A 3-year prognostic score for adults with cystic fibrosis. J Cyst Fibros 2017;16:702-8. [PMID: 28330773 DOI: 10.1016/j.jcf.2017.03.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
30 Elborn JS, Bell SC, Madge SL, Burgel PR, Castellani C, Conway S, De Rijcke K, Dembski B, Drevinek P, Heijerman HG, Innes JA, Lindblad A, Marshall B, Olesen HV, Reimann AL, Solé A, Viviani L, Wagner TO, Welte T, Blasi F. Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis. Eur Respir J 2016;47:420-8. [PMID: 26453627 DOI: 10.1183/13993003.00592-2015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 62] [Article Influence: 11.3] [Reference Citation Analysis]
31 Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, Sermet-Gaudelus I, Southern KW, Barben J, Flume PA, Hodková P, Kashirskaya N, Kirszenbaum MN, Madge S, Oxley H, Plant B, Schwarzenberg SJ, Smyth AR, Taccetti G, Wagner TOF, Wolfe SP, Drevinek P. ECFS best practice guidelines: the 2018 revision. J Cyst Fibros 2018;17:153-78. [PMID: 29506920 DOI: 10.1016/j.jcf.2018.02.006] [Cited by in Crossref: 229] [Cited by in F6Publishing: 175] [Article Influence: 57.3] [Reference Citation Analysis]
32 Nanda T, Breazzano MP, Bearelly S. Clinical utility of pre-transplant ophthalmic consultation for lung transplant recipients: implications in the COVID-19 pandemic era. Graefes Arch Clin Exp Ophthalmol 2021;259:1669-71. [PMID: 32572606 DOI: 10.1007/s00417-020-04799-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Shah P, Lowery E, Chaparro C, Visner G, Hempstead SE, Abraham J, Bhakta Z, Carroll M, Christon L, Danziger-Isakov L, Diamond JM, Lease E, Leonard J, Litvin M, Poole R, Vlahos F, Werchan C, Murray MA, Tallarico E, Faro A, Pilewski JM, Hachem RR. Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients. J Heart Lung Transplant 2021;40:539-56. [PMID: 34103223 DOI: 10.1016/j.healun.2021.04.011] [Reference Citation Analysis]
34 Somayaji R, Nichols DP, Bell SC. Cystic fibrosis - Ten promising therapeutic approaches in the current era of care. Expert Opin Investig Drugs 2020;29:1107-24. [PMID: 32744089 DOI: 10.1080/13543784.2020.1805733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Orlando V, Morin G, Laffont A, Lénart D, Solórzano Barrera C, Mustafy T, Sankhe S, Villemure I, Mailhot G. CFTR deletion affects mouse osteoblasts in a gender-specific manner. J Cell Physiol 2020;235:6736-53. [PMID: 31985038 DOI: 10.1002/jcp.29568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Athanazio RA, Silva Filho LVRF, Vergara AA, Ribeiro AF, Riedi CA, Procianoy EDFA, Adde FV, Reis FJC, Ribeiro JD, Torres LA, Fuccio MB, Epifanio M, Firmida MC, Damaceno N, Ludwig-Neto N, Maróstica PJC, Rached SZ, Melo SFO; Grupo de Trabalho das Diretrizes Brasileiras de Diagnóstico e Tratamento da Fibrose Cística. Brazilian guidelines for the diagnosis and treatment of cystic fibrosis. J Bras Pneumol 2017;43:219-45. [PMID: 28746534 DOI: 10.1590/S1806-37562017000000065] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]